Target Name: GINS complex
NCBI ID: P15674
Other Name(s): None

GINS complex: A drug target and potential biomarker

GINS complex, a protein that plays a crucial role in intracellular signaling, has been identified as a potential drug target and a biomarker for various diseases, including cancer, neurodegenerative disorders, and metabolic diseases. Its unique structure and function make it an attractive target for drug development, and its involvement in multiple cellular processes makes it a valuable biomarker for diagnostic purposes.

GINS complex is composed of three subunits: GINS1, GINS2, and GINS3. These subunits are held together by multiple disulfide bonds, forming a trimeric structure. The N-terminus of each subunit contains a unique domain that is specific for GINS1-interactive proteins, while the C-terminus of each subunit contains a common domain that is involved in protein-protein interactions. The middle domain of each subunit contains a unique protein domain that is specific for GINS2-interactive proteins.

GINS complex plays a central role in intracellular signaling by regulating the activity of various cellular signaling pathways. It is involved in the regulation of cell adhesion, migration, and the cytoskeleton, as well as in the regulation of cytokinesis, cell survival, and apoptosis. GINS complex is also involved in the regulation of ion channels, including the Na+/K+-ATPase, which is a critical regulator of cell signaling and is involved in many cellular processes, including muscle contractions, nerve impulse conduction, and intracellular signaling.

GINS complex is a drug target of great interest due to its involvement in multiple cellular processes that are often disrupted in diseases, including cancer, neurodegenerative disorders, and metabolic diseases. For example, GINS complex is involved in the regulation of cell adhesion and migration, which are critical processes for the development and progression of cancer. It is also involved in the regulation of apoptosis, which is a critical mechanism for the elimination of damaged cells in diseases such as neurodegenerative disorders. In addition, GINS complex is involved in the regulation of ion channels, which are critical regulators of many cellular processes, including muscle contractions, nerve impulse conduction, and intracellular signaling. Its involvement in these processes makes it an attractive target for the development of new drugs that can treat a wide range of diseases.

GINS complex has also been identified as a potential biomarker for several diseases, including cancer, neurodegenerative disorders, and metabolic diseases. Its involvement in the regulation of cellular signaling pathways makes it an attractive target for the development of new diagnostic tools. For example, GINS complex is involved in the regulation of cell adhesion and migration, which are critical processes for the development and progression of cancer. The regulation of these processes can be used as a biomarker for the diagnosis of cancer, including early detection and monitoring of recurrence. In In addition, GINS complex is involved in the regulation of apoptosis, which is a critical mechanism for the elimination of damaged cells in diseases such as neurodegenerative disorders. The regulation of apoptosis can be used as a biomarker for the diagnosis and treatment of these disorders.

GINS complex is also involved in the regulation of cytokinesis, which is the process by which eukaryotic cells produce new cells after division. Its involvement in this process makes it an attractive target for the development of drugs that can regulate cell proliferation and the formation of new cells in diseases such as cancer. In addition, GINS complex is involved in the regulation of ion channels, which are critical regulators of many cellular processes, including muscle contractions, nerve impulse conduction, and intracellular signaling. Its involvement in these processes makes it an attractive target for the development of new drugs that can modulate these channels and treat a wide range of diseases.

In conclusion, GINS complex is a protein that plays a crucial role in intracellular signaling and has been identified as a potential drug target and a biomarker for various diseases, including cancer, neurodegenerative disorders, and metabolic diseases. Its unique structure and function make it an attractive target for drug development, and its involvement in multiple cellular processes makes it a valuable biomarker for diagnostic purposes. Further research is needed to fully understand the role of GINS complex in

Protein Name: GINS Complex

More Common Targets

GINS1 | GINS2 | GINS3 | GINS4 | GIP | GIPC1 | GIPC2 | GIPC3 | GIPR | GIT1 | GIT2 | GJA1 | GJA10 | GJA1P1 | GJA3 | GJA4 | GJA5 | GJA8 | GJA9 | GJA9-MYCBP | GJB1 | GJB2 | GJB3 | GJB4 | GJB5 | GJB6 | GJB7 | GJC1 | GJC2 | GJC3 | GJD2 | GJD3 | GJD4 | GK | GK2 | GK3 | GK5 | GKAP1 | GKN1 | GKN2 | GKN3P | GLA | GLB1 | GLB1L | GLB1L2 | GLB1L3 | GLC1C | GLCCI1 | GLCCI1-DT | GLCE | GLDC | GLDN | GLE1 | GLG1 | GLI1 | GLI2 | GLI3 | GLI4 | GLIDR | GLIPR1 | GLIPR1L1 | GLIPR1L2 | GLIPR2 | GLIS1 | GLIS2 | GLIS3 | GLIS3-AS1 | GLMN | GLMP | GLO1 | GLOD4 | GLOD5 | GLP1R | GLP2R | GLRA1 | GLRA2 | GLRA3 | GLRA4 | GLRB | GLRX | GLRX2 | GLRX3 | GLRX3P2 | GLRX5 | GLS | GLS2 | GLT1D1 | GLT6D1 | GLT8D1 | GLT8D2 | GLTP | GLTPD2 | Glucagon-like peptide receptor (GLP-R) | Glucosidase | GLUD1 | GLUD1P2 | GLUD1P3 | GLUD2 | GLUL | GLULP2